COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES

RAPT Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results

March 11, 2021



« back to news page